During Fall 2017, we will continue to evaluate diabetes treatment benchmarking tools. The primary purpose of these tools is to help patients and care givers understand how people differ in their responses to the same treatments personalized by several characteristics such as starting HbA1c, age, gender, race and ethnicity, education, income, patient reports of psychological distress and well being, symptom distress and patient treatment satisfaction. The Benchmarking tools will also allow one to see how the differences among therapies vary by differences in these personal patient characteristics.
If you are interesting in participating, please send us your contact information by completing this survey – Click Here
Sergio Saldivar
Please try the benchmarking tools during the Summer 2017 Evaluation Period! Cheers!